IBDEI20E ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,32064,2)
 ;;=^121763
 ;;^UTILITY(U,$J,358.3,32065,0)
 ;;=A64.^^126^1644^21
 ;;^UTILITY(U,$J,358.3,32065,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32065,1,3,0)
 ;;=3^Venereal Disease
 ;;^UTILITY(U,$J,358.3,32065,1,4,0)
 ;;=4^A64.
 ;;^UTILITY(U,$J,358.3,32065,2)
 ;;=^5000362
 ;;^UTILITY(U,$J,358.3,32066,0)
 ;;=A04.71^^126^1644^7
 ;;^UTILITY(U,$J,358.3,32066,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32066,1,3,0)
 ;;=3^Enterocolitis d/t Clostridium Difficile,Recurrent
 ;;^UTILITY(U,$J,358.3,32066,1,4,0)
 ;;=4^A04.71
 ;;^UTILITY(U,$J,358.3,32066,2)
 ;;=^5151291
 ;;^UTILITY(U,$J,358.3,32067,0)
 ;;=A04.72^^126^1644^8
 ;;^UTILITY(U,$J,358.3,32067,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32067,1,3,0)
 ;;=3^Enterocolitis d/t Clostridium Difficile,Not Spec as Recurrent
 ;;^UTILITY(U,$J,358.3,32067,1,4,0)
 ;;=4^A04.72
 ;;^UTILITY(U,$J,358.3,32067,2)
 ;;=^5151292
 ;;^UTILITY(U,$J,358.3,32068,0)
 ;;=T81.41XA^^126^1644^13
 ;;^UTILITY(U,$J,358.3,32068,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32068,1,3,0)
 ;;=3^Post-op Wound Infection,Init Encntr
 ;;^UTILITY(U,$J,358.3,32068,1,4,0)
 ;;=4^T81.41XA
 ;;^UTILITY(U,$J,358.3,32068,2)
 ;;=^5157587
 ;;^UTILITY(U,$J,358.3,32069,0)
 ;;=T81.41XD^^126^1644^14
 ;;^UTILITY(U,$J,358.3,32069,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32069,1,3,0)
 ;;=3^Post-op Wound Infection,Subs Encntr
 ;;^UTILITY(U,$J,358.3,32069,1,4,0)
 ;;=4^T81.41XD
 ;;^UTILITY(U,$J,358.3,32069,2)
 ;;=^5157588
 ;;^UTILITY(U,$J,358.3,32070,0)
 ;;=L81.8^^126^1645^1
 ;;^UTILITY(U,$J,358.3,32070,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32070,1,3,0)
 ;;=3^Abnormal Skin Pigment
 ;;^UTILITY(U,$J,358.3,32070,1,4,0)
 ;;=4^L81.8
 ;;^UTILITY(U,$J,358.3,32070,2)
 ;;=^5009318
 ;;^UTILITY(U,$J,358.3,32071,0)
 ;;=L70.0^^126^1645^2
 ;;^UTILITY(U,$J,358.3,32071,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32071,1,3,0)
 ;;=3^Acne Vulgaris
 ;;^UTILITY(U,$J,358.3,32071,1,4,0)
 ;;=4^L70.0
 ;;^UTILITY(U,$J,358.3,32071,2)
 ;;=^5009268
 ;;^UTILITY(U,$J,358.3,32072,0)
 ;;=L65.9^^126^1645^3
 ;;^UTILITY(U,$J,358.3,32072,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32072,1,3,0)
 ;;=3^Alopecia
 ;;^UTILITY(U,$J,358.3,32072,1,4,0)
 ;;=4^L65.9
 ;;^UTILITY(U,$J,358.3,32072,2)
 ;;=^5009252
 ;;^UTILITY(U,$J,358.3,32073,0)
 ;;=L20.89^^126^1645^4
 ;;^UTILITY(U,$J,358.3,32073,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32073,1,3,0)
 ;;=3^Atopic Dermatitis
 ;;^UTILITY(U,$J,358.3,32073,1,4,0)
 ;;=4^L20.89
 ;;^UTILITY(U,$J,358.3,32073,2)
 ;;=^5009112
 ;;^UTILITY(U,$J,358.3,32074,0)
 ;;=D23.9^^126^1645^5
 ;;^UTILITY(U,$J,358.3,32074,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32074,1,3,0)
 ;;=3^Benign Neoplasm,Skin
 ;;^UTILITY(U,$J,358.3,32074,1,4,0)
 ;;=4^D23.9
 ;;^UTILITY(U,$J,358.3,32074,2)
 ;;=^5002076
 ;;^UTILITY(U,$J,358.3,32075,0)
 ;;=L73.8^^126^1645^7
 ;;^UTILITY(U,$J,358.3,32075,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32075,1,3,0)
 ;;=3^Folliculitis,Other Specified
 ;;^UTILITY(U,$J,358.3,32075,1,4,0)
 ;;=4^L73.8
 ;;^UTILITY(U,$J,358.3,32075,2)
 ;;=^5009285
 ;;^UTILITY(U,$J,358.3,32076,0)
 ;;=L28.0^^126^1645^8
 ;;^UTILITY(U,$J,358.3,32076,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32076,1,3,0)
 ;;=3^Lichen Simplex Chronicus
 ;;^UTILITY(U,$J,358.3,32076,1,4,0)
 ;;=4^L28.0
 ;;^UTILITY(U,$J,358.3,32076,2)
 ;;=^259859
 ;;^UTILITY(U,$J,358.3,32077,0)
 ;;=D17.30^^126^1645^9
 ;;^UTILITY(U,$J,358.3,32077,1,0)
 ;;=^358.31IA^4^2
